ID: ALA4287966

Max Phase: Preclinical

Molecular Formula: C20H21N5O3

Molecular Weight: 379.42

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cn1c(N)c(C#N)c2cc(OCc3cccc(NC(=O)C(N)CO)c3)ccc21

Standard InChI:  InChI=1S/C20H21N5O3/c1-25-18-6-5-14(8-15(18)16(9-21)19(25)23)28-11-12-3-2-4-13(7-12)24-20(27)17(22)10-26/h2-8,17,26H,10-11,22-23H2,1H3,(H,24,27)

Standard InChI Key:  ZIXJCLCZPRZPPB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 379.42

Molecular Weight (Monoisotopic): 379.1644

AlogP: 1.47

#Rotatable Bonds: 6

Polar Surface Area: 139.32

Molecular Species: NEUTRAL

HBA: 7

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.17

CX Basic pKa: 7.69

CX LogP: 0.81

CX LogD: 0.35

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.51

Np Likeness Score: -0.89

References

1. Bürli RW, Wei H, Ernst G, Mariga A, Hardern IM, Herlihy K, Cross AJ, Wesolowski SS, Chen H, McKay RDG, Weinberger DR, Brandon NJ, Barrow JC..  (2018)  Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screening.,  28  (19): [PMID:30170942] [10.1016/j.bmcl.2018.08.012]

Source

Source(1):

• Scientific Literature